London Cartilage Clinic
Explore expert articles on cartilage care, regenerative treatments, and practical recovery advice from our specialist team.
ChondroFiller is an injectable collagen hydrogel that sets within three to five minutes, creating a scaffold into which the patient's own repair cells migrate; 81% of patients in published trials achieved good or excellent outcomes with functional gains averaging 30 points on the hip-specific Harris Hip Score.
ChondroFiller lasts substantially longer — 70–85% sustain meaningful relief for three to five years versus six to twelve months for hyaluronic acid — but only because each addresses different pathology: focal cartilage defects through endogenous cell recruitment versus diffuse osteoarthritis through synovial lubrication.
The ChondroFiller injection itself takes minutes, but the regeneration it triggers spans 12–24 months as progenitor cells migrate into the collagen scaffold and gradually replace it with mature cartilage tissue.
When ChondroFiller is injected into the joint, it undergoes pH-triggered gelation; the resulting scaffold recruits the body's own repair cells whilst suppressing MMP-13, the primary cartilage-destroying enzyme.
MACI patients return to desk work within two weeks and normal walking by three months, but return to sport takes closer to a year; the delay reflects how long cartilage graft cells must integrate into the surrounding tissue before the repair can withstand athletic demand.
ChondroFiller achieves 70–85% sustained symptom relief across independent clinical cohorts at five-year follow-up through an acellular collagen scaffold that recruits the patient's own progenitor cells.
